The Latest
Real Talk at SYNChronicity 2020: Black Women Are Essential to Eliminating HIV
Open conversations between care providers and Black women are vitally important in order to empower women with information about HIV and how to protect their health.
This Week in HIV Research: Where the Rubber Meets the Ring
Sep. 10, 2020: Concomitant use of vaginal rings with condoms; benefits of more frequent HIV screening for young MSM; Black MSM, substance use, and the PrEP continuum; HIV outcomes stratified by anti-LGTBQ policy across U.S. states.
Getting PrEP to Those Who Need It During COVID-19 Has Presented New Challenges
Washington, D.C. area community organizations and clinics have moved a lot of prevention efforts online, but much is missing without in-person contact.
This Week in HIV Research: What We Don’t Know Hurts Them
Aug. 20, 2020: HIV knowledge and stigma among health care workers in the southern U.S.; condomless sex vs. HIV risk among MSM; how drug class choice may affect onward transmission risk; STI screening rates among MSM on PrEP.
With Several Curative Therapies for Hepatitis C on the Market, the Research Pipeline for Prevention Continues
The authors of an influential annual report on hepatitis C research and development talk through what's new and evolving in clinical science.
A Vaginal Ring to Prevent HIV Was Given a Positive Opinion by a European Drug Regulator. Here’s What You Need to Know About It.
Two experts discuss the history of the ring, how it works, and when it may come to the United States.
This Week in HIV Research: The Mind Matters
July 23, 2020: Depression and HIV risk mitigation among MSM; a consistent HIV provider is good for CD4 and viral load; spirituality and HIV prevention; HCV treatment access and reinfection risk.
Are Providers Ignoring Anal Sex as a Health Care Issue for Women at Risk for HIV and Cancer?
Recent studies examine the role anal sex is playing in HIV rates and anal cancer among women.
This Week in HIV Research: The Challenges of Our Assumptions
May 28, 2020: Anal lesion recurrence among women with HIV; non-alcoholic fatty liver disease frequency in lean patients; long-term efficacy for a smoking cessation intervention; non-lymphoid cancers following lymphoid malignancy.
Could COVID-19 Contact Tracing Also Help End HIV? These Researchers Think So.
Some advocates support it but want to ensure protections against criminalization.